1. Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up)
Primary end point
Nifedipine
Placebo
Normotensive patients
4.28
3.84
Hypertensive patients
4.90
5.61
Lubsen J et al. J Hypertens 2005, 23:

2. Angiography/CABG in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up)
Angiography
Nifedipine
Placebo
Normotensive patients
5.44
6.86
Hypertensive patients
5.50
6.53
CABG
1.48
2.19
1.75
1.94
Lubsen J et al. J Hypertens 2005, 23:

3. Stroke in normotensive and hypertensive patients at baseline (events per 100 patient- years of follow-up)
Any stroke or TIA
Nifedipine
Placebo
Normotensive patients
0.71
0.97
Hypertensive patients
1.31
1.81
Debilitating stroke
0.30
0.26
0.52
0.77
Lubsen J et al. J Hypertens 2005, 23:

4. New overt heart failure in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up)
New overt heart failure
Nifedipine
Placebo
Normotensive patients
0.43
0.50
Hypertensive patients
0.49
0.78
Lubsen J et al. J Hypertens 2005, 23: